Public programme evaluation studies
Since 1999, the OFDT has been evaluating drug-related public policy. The studies conducted are of themes that are of particular interest for current public policy strategies or "key" measures or programmes, or of areas that present an approach to assessing the plans of the French government.
Until now, the work performed has been on a variety of subjects, such as: treatment; prisoner treatment; counselling clinics for young users (CJC); opioid substitution treatments (OST); Harm Reduction (HR); prevention; law enforcement and the penal response; governmental policy evaluation.
The ban on sales of alcohol and tobacco to minors
Tendances N° 87, September 2013
Awareness courses on the dangers of drug and alcohol use
Tendances N° 81, June 2012
The criminalization of drug use in France
Tendances N° 72, October 2010
Three-year assessment of the counselling cannabis clinics for young users (2005-2007)
Tendances N° 63, December 2008
The initial prescription of methadone in health establishments
Tendances N° 60, April 2008
Substitution and reincarceration - Elements for an analysis of a complex relationship
Tendances N° 57, December 2007
Initial assessment of outpatient visits to the cannabis abuse clinics
Tendances N° 50, September 2006
Excessive use of alcohol and local medical practice - The promotion of early detection and short-term intervention (RPIB)
Tendances N° 47, March 2006
Trends in the care of drug addicts - Survey among general practitioners in 2001 and comparison 92-95-98-2001
Tendances N° 20, March 2002
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.
Country drug reports 2017
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.